John Tumbush, DO
Family Medicine · Middlefield, OHNPI 1932200573
Payments from drug & device makers
Across 172 payments — averaging $15.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$673
- Pfizer$255
- Novo Nordisk$200
- AstraZeneca$143
- Lilly USA, LLC$138
- GSK$115
- plus $1K from 29 others
What the payments were for
- Food & beverage$2,66599%
- Education$351%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 41 | $673 |
| Pfizer | 14 | $255 |
| Novo Nordisk | 13 | $200 |
| AstraZeneca | 11 | $143 |
| Lilly USA, LLC | 9 | $138 |
| GSK | 8 | $115 |
| Merck | 8 | $114 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $97 |
| Sanofi-aventis U.S. LLC | 6 | $95 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $88 |
| Boehringer Ingelheim | 6 | $84 |
| Johnson & Johnson | 5 | $65 |
| Novartis | 4 | $59 |
| Exact Sciences | 3 | $58 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| Bayer | 3 | $49 |
| Abbott | 2 | $42 |
| Kowa Pharmaceuticals America, Inc. | 3 | $38 |
| Amarin Pharma, Inc. | 2 | $37 |
| PTC Therapeutics, Inc. | 1 | $35 |
| Amgen | 2 | $30 |
| Currax Pharmaceuticals LLC | 2 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Sobi, Inc | 1 | $22 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $19 |
| Lundbeck LLC | 1 | $18 |
| Shire North American Group Inc | 1 | $18 |
| Biohaven Pharmaceuticals, Inc. | 1 | $16 |
| Bausch Health US, LLC | 1 | $15 |
| Philips North America LLC | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Amneal Pharmaceuticals LLC | 1 | $11 |
| Nalpropion Pharmaceuticals LLC | 1 | $11 |
How this compares
$2,700 in reported general payments places this provider in the 75th percentile of 3,983 family medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 46 | $48,732 |
| JardianceEmpagliflozin | 12 | $10,179 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $8,180 |
| Rosuvastatin Calcium | 127 | $1,878 |
| Atorvastatin Calcium | 99 | $1,040 |
| Tadalafil | 11 | $894 |
| Duloxetine Hcl | 18 | $864 |
| Gabapentin | 34 | $858 |
| Potassium Chloride | 24 | $714 |
| Losartan Potassium | 71 | $685 |
| Levothyroxine Sodium | 68 | $653 |
| Omeprazole | 31 | $578 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $429 |
| Tamsulosin Hcl | 39 | $426 |
| Escitalopram Oxalate | 33 | $424 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $255 | $48,73246 claims |
| Boehringer IngelheimJardiance | $84 | $10,17912 claims |
| GSKTrelegy Ellipta | $115 | $8,18011 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $11 | $65368 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Middlefield
- Michael ButcherCincinnati$18.3M
- William RandallKettering$7.5M
- Paul NugentCincinnati$4.9M
- Steve ChoiDayton$4.8M
- Martin SchearDayton$2.2M
- Rajesh DavitCincinnati$2M
- Kwabena OtengSpringdale$2M
- Blaise GattoMoraine$1.8M
- Cathy GreiweColumbus$1.4M
- Brian BeesleyColumbus$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.